3 matches for your search in the start-up spotlight
rss
Glox Therapeutics is developing a pipeline of engineered precision bacteriocins targeting pathogens that cause serious infections associated with high levels of antimicrobial resistance (AMR) and mortality. These novel precision antibiotics have potent narrow-spectrum activity to target ...
Microplate Dx are an award winning spinout company from the University of Strathclyde in Glasgow, specialising in developing novel diagnostic solutions to tackle the major global health threat of antimicrobial resistance. The Microplate Dx technology is based on the simple yet highly innovative ...
DeepMatter Group Plc is a big data and analysis company which has built a platform - DigitalGlassware™, focused on enabling reproducibility in chemistry. It continues to develop this software to deliver applications resulting in new optimised chemicals, materials and formulations in such ...
